June 2026 - Channelchek

Release – DLH Announces Leadership Transition

Posted on June 30, 2026June 30, 2026 by [email protected]

June 30, 2026

Zach Parker to Retire; Kathryn JohnBull Appointed CEO; Steve Oroho Appointed CFO

ATLANTA, June 30, 2026 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science research and development solutions to federal agencies, today announced the following leadership changes:

Zach Parker will retire from the role of Chief Executive Officer
The Board has appointed Kathryn JohnBull as CEO
The Board has appointed Steve Oroho as Chief Financial Officer

Zach Parker

Zach Parker will retire as DLH’s Chief Executive Officer and President effective at the close of business on June 30, 2026. To support a smooth leadership transition, Mr. Parker will remain with the Company as an advisor to the Board and incoming CEO through the end of the current fiscal year. He will continue to serve as a member of the Board and beginning in fiscal 2027 will serve as a consultant to the Company in support of certain strategic growth pursuits.

“Sixteen years ago, Zach Parker became the CEO of a $35 million revenue company that was insignificant to the Government Services industry,” said Chairman of the Board Rick Wasserman. “He built a team, and together, they built that organization into the DLH of today. His accomplishments have been exemplary in shaping the Company’s success and creating significant value for our shareholders and career opportunities for our employees. We are grateful for his leadership and pleased that the Company will continue to benefit from his deep industry knowledge, strategic perspective, and longstanding relationships through his continued service on the Board. We are also appreciative that the team he built is uniquely qualified and well positioned to lead us into the future. We wish Zach a long and enjoyable retirement and much happiness in the future.”

“I am proud of what our team has accomplished and excited about DLH’s future,” said Mr. Parker. “After 16 years as CEO, I believe this planned transition represents the right next step for the Company and for me personally. Kathryn has been a close partner, and I have great confidence in her ability to lead the Company through its next chapter. I look forward to supporting Kathryn, the leadership team, and the Board as we continue working to create sustainable long-term value for our shareholders.”

Kathryn JohnBull

Kathryn JohnBull has been appointed as DLH’s Chief Executive Officer and President upon Mr. Parker’s retirement. Ms. JohnBull brings deep public-company leadership experience, financial discipline, and a thorough understanding of the government services market to her new role. She joined DLH as Chief Financial Officer in 2012, and has been central to the Company’s growth, acquisition strategy, capital markets activities, financial operations, and investor engagement.

“Kathryn is exceptionally well prepared to lead DLH at this important moment in the Company’s evolution,” Mr. Wasserman continued. “During her 14 years with us, she has demonstrated a strong combination of leadership skills, financial acumen, operating discipline, customer understanding, and public-company experience. This promotion is well earned, and the Board is confident that Kathryn and her leadership team are well positioned to advance the Company’s strategy and compete for new business opportunities, which create value for our shareholders.”

“I am honored to lead DLH as we enter the next stage of our corporate journey,” said Ms. JohnBull. “Our company has been built by talented people, highly valued customer relationships, and an unwavering commitment to supporting critical government missions. As we look ahead, our focus will be clear: executing with discipline and excellence, delivering exceptional value for our customers, and investing in and empowering our employees. By embracing innovation and strengthening the capabilities that differentiate DLH, we will continue building a company where our employees will grow, our customers will be well served, and our business will thrive.”

Steve Oroho

Steve Oroho has been appointed as DLH’s Chief Financial Officer and Treasurer upon Ms. JohnBull’s appointment as CEO. Mr. Oroho joined DLH in 2018 and has served as Senior Vice President, Finance & Accounting. In that role, he has played an important part in the Company’s financial reporting, strategic planning, accounting, treasury, and business operations support. As Chief Financial Officer, Mr. Oroho will lead DLH’s finance organization, including accounting, financial planning and analysis, treasury, tax, investor relations, and related financial operations.

“Steve has been an important member of DLH’s finance leadership team and brings deep knowledge of the Company’s operations, financial systems, and strategic priorities,” said Ms. JohnBull. “His experience, judgment, and commitment to disciplined execution will serve DLH well as we continue to advance our strategic and financial objectives.”

“I am grateful for the opportunity to serve as DLH’s Chief Financial Officer,” said Mr. Oroho. “I look forward to continuing to work closely with Kathryn, the Board, and our leadership team to support our customers, strengthen our operating performance, and create sustainable value for our shareholders.”

About DLH:

DLH (NASDAQ: DLHC) enhances technology, public health, and cyber security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With a world-class workforce dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions. For more information, visit www.DLHcorp.com.

Contact Information:

Investor Relations
Chris Witty
(646) 438-9385
[email protected]

Media
[email protected]

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding the anticipated use of proceeds. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements due to a variety of factors, including: the failure to achieve the anticipated benefits of any future acquisition (including anticipated future financial operating performance and results); the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities; legal, regulatory, and political changes from the federal government that could result in economic uncertainty; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather based on current expectations, estimates, assumptions and projections about our industry and business.

Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

Release – Conduent Announces Agreement to Sell Its Tolling Business to Quarterhill Inc. for $70 Million

Posted on June 30, 2026June 30, 2026 by [email protected]

Research News and Market Data on CNDT

Conduent Bolsters Financial Position Tolling Agreement Follows Recently Announced Agreement to Sell Its Public Transit Business

June 30, 2026

Corporate Transportation

Conduent Will Also Receive a 7% Interest in Quarterhill Inc.

Conduent Bolsters Financial Position

Tolling Agreement Follows Recently Announced Agreement to Sell Its Public Transit Business

FLORHAM PARK, N.J., June 30, 2026 — Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services provider, today announced that it has entered into a definitive agreement to sell its Tolling business (a division of Conduent Transportation) to Quarterhill Inc. (TSX: QTRH) (OTCQX: QTRHF), a leading global provider of intelligent transportation system solutions.

The sale has a purchase price of $70 million in cash, and Quarterhill will assume most liabilities associated with the business, including all surety bond obligations, further improving Conduent’s financial profile. The structure of the transaction enhances Conduent’s financial flexibility and reduces exposure to non-core obligations.

The transaction is expected to close before the end of 2026.

This agreement follows a separate transaction, announced in May, to sell the Public Transit business, also part of Conduent’s Transportation division, which is similarly expected to close before the end of 2026.

Together, these transactions simplify Conduent’s portfolio and increase focus on its core businesses, enhancing the predictability and durability of Conduent’s earnings profile.

“This Tolling transaction, alongside the previously announced Public Transit agreement, advances our strategy to simplify our portfolio, sharpen focus on our core businesses, and strengthen our financial foundation,” said Harsha V. Agadi, Conduent President and Chief Executive Officer. “We are continuing our strategic journey to enhance long-term value creation, including simplifying our business, strengthening the balance sheet, and increasing sustainable free cash flow.

“With more than four decades of experience in tolling, Quarterhill is extremely well positioned to support the Conduent Tolling team and its clients. As we move toward closing, we remain committed to delivering outstanding quality and performance for all Transportation clients while ensuring smooth transitions for both clients and associates.”

As part of the transaction, Conduent will also receive a 7% interest in Quarterhill Inc. along with registration rights and board observer rights, providing potential upside participation in future value creation.

With operations in the United States and United Kingdom, Conduent’s Tolling business provides mission‑critical technology that enables all‑electronic tolling, roadside and back‑office processing, image review, violation enforcement, and analytics. It supports more than 14 million tolling transactions per day.

Additional details of the transaction are outlined in Conduent’s 8-K filed with the U.S. Securities and Exchange Commission (SEC) today.

About Conduent
Conduent delivers digital business solutions and services spanning the commercial, government and transportation spectrum – creating valuable outcomes for its clients and the millions of people who count on them. The Company leverages cloud computing, artificial intelligence, machine learning, automation and advanced analytics to deliver mission-critical solutions. Through a dedicated global team of approximately 48,000 associates, process expertise and advanced technologies, Conduent’s solutions and services digitally transform its clients’ operations to enhance customer experiences, improve performance, increase efficiencies and reduce costs. Conduent adds momentum to its clients’ missions in many ways including disbursing approximately $80 billion in government payments annually, enabling approximately 2.0 billion customer service interactions annually, empowering millions of employees through HR services every year and processing over 14 million tolling transactions every day. Learn more at www.conduent.com.

About Quarterhill
Quarterhill is a global leader in the Intelligent Transportation System (ITS) industry, advancing mobility through smart infrastructure solutions that reduce congestion, improve roadway safety, and create more sustainable travel. Each year, Quarterhill’s platforms process billions of transactions, perform compliance and safety inspections on millions of commercial vehicles, and enable transportation agencies worldwide to optimize thousands of lanes of traffic to improve travel for everyone. Leveraging advanced artificial intelligence and machine learning technologies, Quarterhill’s platform delivers automation and predictive insight to help agencies manage transportation networks more efficiently. By working in close partnership with governments, communities, and industry leaders, Quarterhill is building today’s connected roadways while shaping the next generation of intelligent, resilient mobility. Quarterhill is listed on the TSX under the symbol QTRH and on the OTCQX Best Market under the symbol QTRHF. Learn more at www.quarterhill.com.

###

Media Contacts

Remy Kaul

Conduent

[email protected]

Lands’ End Announces CEO Transition, Positioning Company for Next Phase of Growth

Posted on June 30, 2026June 30, 2026 by [email protected]

Research News and Market Data on LE

Jun 30, 2026

Consumer Brand and Digital Transformation Executive Charlie Cole Named Chief Executive Officer

Andrew McLean to Transition to Advisory Role to Support Smooth Transition

DODGEVILLE, Wis., June 30, 2026 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced that its Board of Directors has appointed consumer brand and digital transformation executive Charlie Cole as Chief Executive Officer and a member of the Board of Directors, effective July 13, 2026. Mr. Cole will succeed Andrew McLean, who will step down as CEO and a member of the Board of Directors.

Mr. Cole’s appointment builds on the strong execution of the Company’s solutions-based strategy under Mr. McLean that strengthened the Lands’ End brand, improved operating performance, repositioned the Company for long-term growth, and culminated in the Company’s strategic joint venture with WHP Global.

“Our responsibility as a Board is to ensure Lands’ End has the right leader for every stage of its evolution,” said Josephine Linden, Chair of the Board of Directors. “Charlie has spent his career transforming iconic consumer brands by combining disciplined operating execution with technology-enabled innovation, and the Board is confident that his expertise will enable him to execute and expand on the strategy the Company recently laid out while positioning Lands’ End exceptionally well to drive the next phase of profitable growth and sustainable shareholder value creation.”

Mr. Cole said, “Lands’ End is one of America’s most iconic brands, built on quality, service, and enduring customer relationships. Andrew and the entire team have created a strong platform for the future, and I am honored to build upon that foundation, leveraging my technology and AI experience to create an even more personalized, engaging and productive customer experience. I look forward to working alongside Lands’ End’s talented employees, partners, customers and shareholders as we write the next chapter of the Lands’ End story.”

Mrs. Linden added: “On behalf of the Board, I want to thank Andrew for his outstanding leadership. During his tenure, Lands’ End executed a strategic transformation that strengthened both the business and the balance sheet and created meaningful opportunities for future value creation. Andrew’s leadership in establishing the WHP Global joint venture represents a significant milestone in unlocking the long-term potential of the Lands’ End brand. We are grateful that he will continue supporting the Company during this transition.”

“The continued return of capital to shareholders through the Company’s $100 million share repurchase program authorized in April is demonstration of the Board’s confidence in the future and value of this great Company,” concluded Mrs. Linden.

Mr. McLean said: “It has been a privilege to lead Lands’ End and work alongside such an exceptional team. Together we strengthened the brand, improved our operating performance, expanded strategic opportunities, and positioned the Company for its next phase of growth. I have tremendous confidence in Charlie’s leadership and believe Lands’ End is well positioned to continue creating value for customers, employees and shareholders. I remain committed to ensuring a smooth transition.”

The Board retained leading executive search firm Heidrick & Struggles to assist in its search.

Charlie Cole Biography

Charlie Cole is a consumer brand executive with more than two decades of leadership experience spanning digital commerce, technology, artificial intelligence and omnichannel retail. Most recently, he served as Interim Chief Digital Officer of Thuma. Previously, he was President of XGen AI, an AI-powered commerce software company acquired by Zoovu in 2026, Chief Executive Officer of Tribute Technology, Chief Executive Officer of FTD, Chief Digital Officer of TUMI, and Global Chief eCommerce Officer of Samsonite. Throughout his career, Mr. Cole has helped iconic consumer brands accelerate growth through customer-centric innovation, digital transformation and operational excellence. He holds a Bachelor of Arts in Business Administration from the University of Washington.

About Lands’ End, Inc.

Lands’ End, Inc. (NASDAQ:LE) is a leading digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products and uniforms. Lands’ End offers products online at www.landsend.com, through third-party distribution channels and our own Company Operated stores. Lands’ End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. Lands’ End is a classic American lifestyle brand that creates solutions for life’s every journey.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding positioning the Company for growth and value; the expected timing and effect of the CEO transition and the appointment of Mr. Cole; the Board ensuring future leadership; confidence in executing and expanding strategy, building on the Company’s platform, improved customer experience and the Company’s next chapter; the long-term potential of the Lands’ End brand; the share repurchase program and its anticipated scale and impact; and the future value of the Company. Forward-looking statements are based on beliefs and assumptions and are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if the underlying beliefs and assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. These risks and uncertainties include those risks, uncertainties and factors discussed in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended January 30, 2026 and “Part II, Item 1A Risk Factors” of the Quarterly Report on Form 10-Q for the quarter ended May 1, 2026. Forward-looking statements speak only as of the date on which they are made. The Company expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable securities laws and regulations.

CONTACTS:

Investors:
Lands’ End, Inc.
Bernard McCracken
Chief Financial Officer
(608) 935-4100

ICR, Inc.
Tom Filandro
(646) 277-1235
[email protected]

Media:
FGS Global
Andy Duberstein/Hayley Cook
[email protected]

Release – Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

Posted on June 30, 2026June 30, 2026 by [email protected]

Research News and Market Data on UNCY

June 30, 2026 7:05am EDT Download as PDF

— Complete Response Letter relates to deficiencies previously identified at third-party manufacturing vendor —

— FDA inspection of third-party facility did not occur during the NDA resubmission review —

— Labeling discussions currently underway; latest communication received by the Company from FDA on June 29 regarding carton and container label —

— FDA did not raise concerns regarding the clinical efficacy or safety data of OLC, and no additional data was requested —

MOUNTAIN VIEW, Calif., June 30, 2026 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the resubmitted New Drug Application (NDA) for oxylanthanum carbonate (OLC) for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. The FDA has not raised any concerns regarding clinical efficacy or safety data, and no additional data was requested from Unicycive.

The CRL is based on the same third-party manufacturing deficiencies that were identified in the previous CRL issued in June 2025. Unicycive understands that the FDA has not yet conducted its inspection of that third-party manufacturing vendor as part of the review process of the resubmitted NDA. The NDA for OLC had been resubmitted based on Unicycive’s belief of continued progress by the original third-party manufacturing vendor in resolving FDA-cited deficiencies and demonstrating inspection readiness. Unicycive previously discussed these milestones during a Type A meeting with the FDA in September 2025, which was held to obtain feedback and alignment on resolving the deficiencies identified in the Company’s CRL related to the compliance status of the vendor. The FDA did not express any concerns about the third-party manufacturer’s progress and no additional issues were raised by the FDA at the Type A meeting.

“We remain confident in the efficacy and safety of OLC,” said Shalabh Gupta, M.D., Chief Executive Officer of Unicycive. “We are in active and ongoing discussion with the FDA regarding label and packaging, and we are optimistic that there will be a successful inspection of the third-party manufacturing vendor and that we will be able to expeditiously resubmit the NDA.”

The OLC NDA is supported by data from three clinical studies: a Phase 1 study in healthy volunteers, a bioequivalence study in healthy volunteers, and a tolerability study of OLC in chronic kidney disease (CKD) patients on dialysis, multiple preclinical studies, as well as chemistry, manufacturing and controls (CMC) data.

About Oxylanthanum Carbonate
OLC is an investigational oral phosphate binder that leverages proprietary nanoparticle technology to deliver high phosphate binding potency, reducing the number and size of pills that patients must take to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Its potential best-in-class profile may have meaningful patient adherence benefits over currently available treatment options as it requires a lower pill burden.
Unicycive is seeking FDA approval of OLC via the 505(b)(2) regulatory pathway. OLC is protected by a strong global patent portfolio including issued patents on composition of matter with exclusivity until 2031, and with the potential for patent term extension until 2035.

About Hyperphosphatemia
Hyperphosphatemia is a serious medical condition that occurs in nearly all patients with End Stage Renal Disease (ESRD). Annually there are over 450,000 individuals in the U.S. that require medication to control their phosphate levels.¹ Uncontrolled hyperphosphatemia is strongly associated with increased death and hospitalization for CKD patients on dialysis. Treatment of hyperphosphatemia is aimed at lowering serum phosphate levels via two means: (1) restricting dietary phosphorus intake; and (2) using, on a daily basis, and with each meal, oral phosphate binding drugs that facilitate fecal elimination of dietary phosphate rather than its absorption from the gastrointestinal tract into the bloodstream.

¹Flythe JE. Dialysis-Past, Present, and Future: A Kidney360 Perspectives Series. Kidney360. 2023 May 1;4(5):567-568. doi: 10.34067/KID.0000000000000145.

About Unicycive Therapeutics
Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. For more information, please visit Unicycive.com and follow us on LinkedIn and X.

Forward-looking statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified using words such as “anticipate,” “believe,” “forecast,” “estimated” and “intend” or other similar terms or expressions that concern Unicycive’s expectations, strategy, plans or intentions. These forward-looking statements are based on Unicycive’s current expectations and actual results could differ materially. There are several factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, clinical trials involve a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future trial results; our clinical trials may be suspended or discontinued due to unexpected side effects or other safety risks that could preclude approval of our product candidates; risks related to business interruptions, which could seriously harm our financial condition and increase our costs and expenses; our need to raise substantial additional capital in the future to fund our continuing operations and the development and commercialization of our current product candidates and future product candidates; dependence on key personnel; substantial competition; uncertainties of patent protection and litigation; dependence upon third parties; risks related to delays in obtaining or failure to obtain FDA clearances or approvals and noncompliance with FDA regulations; and our failure, or the failure of our third-party manufacturers, or their subcontractors, to comply with cGMPs or other applicable regulations, which could result in sanctions being imposed on us or the manufacturers, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates, operating restrictions and criminal prosecutions, any of which could adversely affect supplies of our product candidates and harm our business and results of operations. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled ‘Risk Factors’ in Unicycive’s Annual Report on Form 10-K for the year ended December 31, 2025, and other periodic reports filed with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Unicycive specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor Contact:
Kevin Gardner
LifeSci Advisors
[email protected]

Media Contact:
Layne Cosgrove
Real Chemistry
[email protected]

Source: Unicycive Therapeutics, Inc.

Released June 30, 2026

Two RV Component Giants Are Merging to Build an $8.1 Billion Outdoor Powerhouse

Posted on June 30, 2026June 30, 2026 by [email protected]

Two of the most important names in the recreational vehicle and outdoor recreation supply chain are joining forces. Patrick Industries (Nasdaq: PATK) and LCI Industries (NYSE: LCII) the latter known commercially as Lippert announced Tuesday they have entered into a definitive agreement to combine in an all-stock merger, creating a premier component solutions provider serving the outdoor enthusiast, housing, and transportation markets. The boards of both companies unanimously approved the transaction.

Under the terms, LCI shareholders will receive 1.2440 shares of Patrick common stock for each LCI share they own. When the deal closes, Patrick shareholders will own approximately 52% of the combined company and LCI shareholders approximately 48% — a near-even split that reflects the comparable scale of the two businesses.

The Scale of the Combined Company

The merger creates a genuine industry heavyweight. On a pro forma basis, the combined company would have generated approximately $8.1 billion in revenue over the trailing twelve months as of March 2026, with adjusted EBITDA of $1.0 billion and free cash flow of $508 million, both inclusive of expected synergies. Those are substantial figures in the component manufacturing space and give the combined entity meaningful scale across its end markets.

The financial case rests heavily on cost synergies. Management expects the transaction to deliver more than $150 million in run-rate cost savings within three years of closing. The company describes those synergies as identified and actionable, arising primarily from procurement efficiencies, selling, general and administrative streamlining, shared engineering best practices, and improved supply chain management, the kind of operational overlap that two companies serving similar customers and end markets can realistically capture.

Why These Two Companies Fit Together

Both Patrick and LCI are component solutions providers with deep, longstanding relationships across the recreational vehicle, marine, manufactured housing, and broader outdoor recreation industries. They supply the parts and systems that go into RVs, boats, manufactured homes, and other products built for life outdoors. Their portfolios are complementary rather than overlapping in a way that would raise significant antitrust concern, and both maintain established customer partnerships across North America and Europe.

The combined leadership structure reflects the partnership nature of the deal. Patrick’s Andy Nemeth will serve as CEO of the combined company, while Todd Cleveland will become Chair and LCI’s Johnny Sirpilla will serve as Vice Chair of the board. That distribution of senior roles across both legacy organizations signals an intent to integrate the two cultures rather than have one absorb the other.

The Cyclical Context

The timing of this combination is worth understanding. The recreational vehicle and outdoor recreation industries are highly cyclical, and they have navigated a challenging stretch as elevated interest rates pressured big-ticket discretionary purchases like RVs and boats throughout 2025 and into 2026. By combining, Patrick and LCI gain the scale, cost structure, and balance sheet flexibility to weather cyclical downturns more effectively and to invest through the cycle rather than retrench during it.

For investors tracking the small and mid cap industrial and consumer discretionary space, this merger carries a familiar signal. In sectors facing cyclical pressure and margin compression, scale becomes a defensive advantage. Companies with complementary products and overlapping cost structures are increasingly choosing to combine rather than compete, pooling resources to improve procurement leverage, operational efficiency, and resilience. The outdoor recreation supply chain just produced one of the clearest examples of that logic in 2026 at $8.1 billion in combined revenue, the resulting company will be a dominant force in its markets when conditions in the RV and outdoor industries eventually turn back up.

Star Equity Holdings, Inc. (STRR) – A First Step

Posted on June 30, 2026June 30, 2026 by [email protected]

Tuesday, June 30, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Russell Microcap Index. Star Equity Holdings’ common stock has been added to the Russell Microcap® Index following the 2026 Russell indexes reconstitution, which became effective after the U.S. market close on June 26, 2026. We view the inclusion of Star in the Microcap Index as the first step in management’s goal to be added to the Russell 2000 Index.

Russell Microcap Index. The reconstitution of the Russell U.S. Indexes captures the 4,000 largest U.S. stocks as of April 30, 2026, ranked by total market capitalization. The Russell Microcap® Index measures the performance of the microcap segment of the U.S. equity market and is used by institutional investors and investment managers as a benchmark for microcap equities.

Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.

NN (NNBR) – Expanding Data Center Business

Posted on June 30, 2026June 30, 2026 by [email protected]

Tuesday, June 30, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New Awards. NN has secured a significant amount of additional 2026 immediate-supply awards for liquid cooling products that go into NVIDIA AI data center racks. The new awards are additive to prior communicated awards and greatly increase the size of NN’s liquid cooling product portfolio for AI data center racks. NN’s combined Data Center and Electric Grid business is already its 2nd-largest business, with a goal to grow it into the Company’s largest business by sales. The Data Center & Electric Grid end markets are the top targeted growth markets for the Company.

Successful Launch. In 1Q26, NN announced the launch of a custom-designed stainless-steel product line for the liquid-cooled data center market. Since then, the Company has secured multiple AI data center awards, invested in an initial complement of 17 next-generation, high-speed, high-precision CNC machines at its Wuxi, China, plant, and begun production.

Get the Full Report

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

Russell Reconstitution 2026 Takes Effect: 237 New Names Join the Small Cap Index

Posted on June 30, 2026June 30, 2026 by [email protected]

The Russell US Indexes reconstitution that we previewed earlier this month officially took effect at the close of trading Friday, and US markets opened this morning, Monday June 29, with the newly recalibrated indexes in operation. The timing is notable. Just last week we wrote about the market rotation finally broadening beyond a handful of mega cap technology names and into small caps — and this reconstitution is the structural machinery that formalizes exactly that shift, recalibrating which companies sit in which index after a year of dramatic movement across the market cap spectrum.

After a query period, a lock-down phase, and one of the highest-volume trading sessions of the year on Friday, the 2026 reconstitution is now complete — and the changes offer a revealing snapshot of how the US equity market has evolved over the past twelve months.

A Market That Grew 29% in a Year

The headline figure is the scale of the market’s expansion. The total market capitalization of the Russell 3000 — the broad index designed to capture roughly 98% of the investable US equity market — rose 29% from $58.4 trillion at last year’s reconstitution to $75.6 trillion as of the April 30 rank day. That growth rippled through every layer of the index family. The market capitalization breakpoint separating large-cap companies in the Russell 1000 from small-cap companies in the Russell 2000 increased 24% to $5.7 billion. At the lower boundary, the smallest company in the Russell 2000 now carries a market cap of approximately $146 million, up nearly 23% from a year ago.

A Historic Shakeup at the Top

One of the most striking changes occurred among the largest companies in the index. For more than a decade, Apple and Microsoft traded places as the two largest US companies. This year broke that pattern. Driven by the artificial intelligence boom, Nvidia rose from third place in 2025 to become the largest company in both the Russell 3000 and Russell 1000, while Alphabet climbed from fifth to second. Apple and Microsoft slipped to third and fourth. It is the clearest index-level evidence yet of how completely AI has reshaped market leadership.

The Small Cap Story Beneath the Surface

For ChannelChek’s audience, the more relevant action is happening lower down the market cap spectrum. A total of 237 companies were added to the Russell 2000 this cycle, with additions concentrated most heavily in health care, followed by technology, industrials, and consumer discretionary. That cohort includes 82 companies migrating up from the Russell Microcap Index, 37 moving down from the Russell 1000, and 101 newly eligible entrants joining from outside the Russell universe. Seventeen IPOs were added directly to the small cap index, led by eight health care names.

The reconstitution also revealed the strength of the recent small cap surge through its banding mechanism. A remarkable 97 existing Russell 2000 constituents ranked above the large cap breakpoint based on market cap but remained in the small cap index because they fell within the retention band — a buffer designed to reduce unnecessary turnover. That is an unusually high number, and it reflects just how many small cap companies have appreciated toward large cap territory over the past year.

Why the Semi-Annual Shift Matters Going Forward

This reconstitution carries lasting structural significance because 2026 marks the first time since 1989 that FTSE Russell has moved to a semi-annual schedule. A second reconstitution will now occur in December, and the implications are real. With roughly $12 trillion in assets benchmarked to Russell indexes, the addition of a December rebalance means that companies growing rapidly into or shrinking out of an index will be repositioned far faster than the prior annual cadence allowed.

For active small cap managers, that change raises the stakes around benchmark awareness and risk management. Stocks that appreciate quickly can now be migrated to a new index in months rather than waiting a full year, compressing the window in which fundamental changes get reflected in index composition. For investors, the practical takeaway is that index inclusion remains a powerful driver of passive fund flows and liquidity — but inclusion is not the same as fundamental validation. A company can join an index and still carry execution, dilution, or earnings risk. The reconstitution list is best understood as a map of where benchmark-driven attention may flow, not a substitute for due diligence.

The rebalanced indexes are live. The market they represent looks materially different than it did a year ago — larger at the top, broader beneath the surface, and now recalibrated twice as often as it was for the prior 37 years.

Release – NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS

Posted on June 29, 2026June 29, 2026 by [email protected]

Research News and Market Data on NRSN

First randomized, double-blind, placebo-controlled trial to demonstrate treatment-associated reduction of TDP-43 in people living with ALS
TDP-43 pathology is present in more than 97% of ALS cases and is widely recognized as a central driver of disease progression
PrimeC demonstrates target engagement with consistent effects across clinical outcomes, survival, and biomarkers, supporting its potential as a disease-modifying therapy

CAMBRIDGE, Mass., June 29, 2026 /PRNewswire/ — NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, today announced that its Phase 2b PARADIGM study of PrimeC in amyotrophic lateral sclerosis (ALS) has successfully met its primary efficacy endpoint, demonstrating a statistically significant reduction in TDP-43 levels compared to placebo. This is the first randomized, double-blind, placebo-controlled clinical study to demonstrate a treatment-associated reduction in TDP-43 in people living with ALS. The analysis was performed using the NeuroDex ExoSORT procedure, an immunoaffinity-based methodology that selectively isolates neuron-derived extracellular vesicles (NDEs). This approach enables measurement of neuron-derived TDP-43, providing a CNS-relevant signal that can be distinguished from TDP-43 released by non-neuronal cells and peripheral tissues.

TDP-43 is the defining pathological hallmark of ALS, present in more than 97% of cases, and is widely recognized as a central driver of disease progression. The observed reduction in TDP-43 provides biological evidence that PrimeC is engaging a core disease mechanism.

Primary Efficacy Endpoint Achieved with Statistical Significance

The randomized, double-blind, placebo-controlled Phase 2b PARADIGM study evaluated the safety, tolerability, biomarkers and efficacy of PrimeC in people with ALS. At Day 180, the pre-specified primary endpoint timepoint, PrimeC produced a statistically significant reduction in TDP-43 versus placebo (p=0.0421). The effect was sustained and deepened over the full 18 months of the study, with continuously treated PrimeC participants maintaining lower TDP-43 levels than the placebo arm at Day 540 (p<0.001).

These findings build upon previously reported clinical outcomes from the PARADIGM study, including:

Statistically significant slowing of ALSFRS-R decline at 12 and 18 months (36.5%, p=0.008; 32.8%, p=0.007)
Statistically significant ~15-month median survival benefit (HR 0.35, p=0.004)
Consistent modulation of TDP-43, iron-regulatory and ALS-associated microRNA, supporting multi-target engagement
Favorable safety and tolerability profile with no new safety signals observed over up to 18 months of treatment

“Achieving the primary endpoint of PARADIGM with a statistically significant reduction in TDP-43 marks a defining moment for NeuroSense and for ALS research,” said Alon Ben-Noon, Chief Executive Officer of NeuroSense. “For decades, TDP-43 has been recognized as the pathological signature of ALS, yet demonstrating a treatment-associated reduction in people with ALS has remained elusive. Combined with the clinically meaningful slowing of disease progression, significant survival benefit, and consistent biomarker findings previously reported from PARADIGM, these results provide a compelling and highly differentiated body of evidence supporting PrimeC’s potential as a disease-modifying therapy. We believe this growing dataset further validates our scientific approach and positions PrimeC as one of the most comprehensively supported therapeutic candidates in ALS today.”

“One of the central questions in ALS drug development is whether a therapy is truly affecting the underlying biology of the disease,” said Prof. Merit Cudkowicz, MD, MSc, Director of the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, and Professor of Neurology at Harvard Medical School. “The TDP-43 findings reported in PARADIGM are particularly important because they suggest target engagement of a pathological process present in the majority of people with ALS. When viewed together with the previously reported safety, biomarker and clinical outcome data, and the high unmet need, these results provide compelling data supporting advancement into a confirmatory Phase 3 clinical trial.”

“It is remarkable to see that the increase in NDE-associated TDP-43 observed in the placebo group follows the same trajectory as that identified in our longitudinal studies. This effect, together with the positive outcome of PARADIGM, highlights the promise of TDP-43 as a biomarker for monitoring treatment response,” said Dr. Erez Eitan, CEO of NeuroDex.

Having secured FDA clearance to initiate its global Phase 3 (PARAGON) study, NeuroSense is advancing trial preparations while progressing regulatory interactions across multiple jurisdictions, including Canada.

About NeuroSense

NeuroSense Therapeutics is a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease. The Company’s lead product candidate, PrimeC, is a novel oral therapy designed to target multiple key biological pathways underlying disease progression, including neuroinflammation, oxidative stress and dysregulated iron metabolism.

NeuroSense has generated compelling clinical data from its Phase 2b PARADIGM study in ALS, demonstrating meaningful slowing of disease progression. The Company also reported significant biological activity across multiple biomarkers associated with ALS, including microRNAs, supporting PrimeC’s multi-target mechanism of action. Notably, long-term follow-up data indicated a meaningful survival benefit, representing a potentially important advancement in the treatment of ALS.

NeuroSense has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a pivotal Phase 3 clinical trial (PARAGON) in ALS, which is expected to enroll approximately 300 participants, primarily in the United States.

For additional information, we invite you to visit our website and follow us on LinkedIn, YouTube and X. Information that may be important to investors may be routinely posted on our website and these social media channels.

About PrimeC

PrimeC, NeuroSense’s lead drug candidate, is a novel extended-release oral formulation composed of a unique fixed-dose combination of two FDA-approved drugs: ciprofloxacin and celecoxib. PrimeC is designed to synergistically target several key mechanisms of ALS and AD, that contribute to neuron degeneration, inflammation, iron accumulation and impaired ribonucleic acid (“RNA”) regulation to potentially inhibit the progression of ALS and AD.

About ALS

Amyotrophic lateral sclerosis (“ALS”) is an incurable neurodegenerative disease that causes complete paralysis and death within 2-5 years from diagnosis. Every year, more than 5,000 people are diagnosed with ALS in the U.S. alone, with an annual disease burden of $1 billion. The number of people living with ALS is expected to grow by 24% by 2040 in the U.S. and EU.

About ExoSORT and Neuron-derived EV

ExoSORT™ is NeuroDex’s proprietary automated platform for the enrichment of neuron-derived extracellular vesicles (NDEs) from blood samples. Utilizing a combination of highly specific neuronal antibodies and a scalable 96-well workflow, ExoSORT™ selectively isolates extracellular vesicles originating from the brain, increasing the neuronal signal by more than 50-fold compared to conventional plasma analyses.

By enriching for brain-derived vesicles, ExoSORT™ enables detection of disease-associated proteins present in multiple tissues, like TDP-43.

Forward-Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on NeuroSense Therapeutics’ current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict and include statements regarding the potential of PrimeC. Further, certain forward-looking statements, including statements regarding future development of PrimeC, are based on assumptions as to future events that may not prove to be accurate. The future events and trends may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward looking statements. These risks include the uncertainty regarding outcomes and the timing of current and future clinical trials; the risk that PrimeC will not advance towards later-stage development, timing for reporting data, including from the study of PrimeC in Alzheimer’s disease; that the study will not be successful; the ability of NeuroSense to remain listed on Nasdaq; and other risks and uncertainties set forth in NeuroSense’s filings with the Securities and Exchange Commission (SEC). You should not rely on these statements as representing our views in the future. More information about the risks and uncertainties affecting NeuroSense is contained under the heading “Risk Factors” in the Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 31, 2026 and NeuroSense’s subsequent filings with the SEC. Forward-looking statements contained in this announcement are made as of this date, and NeuroSense undertakes no duty to update such information except as required under applicable law.

Logo: https://mma.prnewswire.com/media/1707291/NeuroSense_Therapeutics_Logo.jpg

SOURCE NeuroSense

For further information: For further information: Email: [email protected] | Tel: +972 (0)9 799 6183

Release – Star Equity Holdings Added to the Russell Microcap® Index

Posted on June 29, 2026June 29, 2026 by [email protected]

Research News and Market Data on STRR

Jun 29, 2026

Download PDF

OLD GREENWICH, Conn., June 29, 2026 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR and STRRP) (“Star” or the “Company”), a diversified holding company, announced today the Company’s common stock has been added to the Russell Microcap^® Index following the 2026 Russell indexes reconstitution, which became effective after US market close on June 26, 2026.

The reconstitution of the Russell U.S. Indexes captures the 4,000 largest U.S. stocks as of April 30, 2026, ranked by total market capitalization. The Russell Microcap^® Index measures the performance of the microcap segment of the U.S. equity market and is used by institutional investors and investment managers as a benchmark for microcap equities.

Jeff Eberwein, CEO of Star, commented, “We are pleased to join the Russell Microcap^® Index, a meaningful milestone that reflects our progress in building a diversified platform for long-term shareholder value creation. Inclusion in this benchmark expands our visibility within the institutional investment community and introduces our stock to additional microcap investors seeking fundamentally driven, value-oriented opportunities. We believe this recognition will further broaden awareness as we continue executing on our strategy.”

About Star Equity Holdings, Inc.
Star Equity Holdings, Inc. is a diversified holding company that seeks to build long-term shareholder value by acquiring, managing, and growing businesses with strong fundamentals and market opportunities. Its current structure comprises four segments: Building Solutions, Business Services, Energy Services, and Investments. For more information visit www.starequity.com.

Building Solutions
The Building Solutions division operates in three specialties: (i) modular building manufacturing; (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations; and (iii) glue-laminated timber (glulam) column, beam, and truss manufacturing.

Business Services
The Business Services division provides flexible and scalable recruitment solutions to a global clientele, servicing organizations at all levels, from entry-level positions to the C-suite. The division focuses on mid-market and enterprise organizations worldwide, partnering consultatively with talent acquisition, HR, and procurement leaders to build diverse, high-impact teams and drive business success.

Energy Services
The Energy Services division engages in the rental, sale, and repair of downhole tools used in the oil and gas, geothermal, mining, and water-well industries.

Investments
The Investments division manages and finances the Company’s real estate assets as well as its investment positions in private and public companies.

About FTSE Russell, an LSEG Business
FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally.

FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $21.20 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives.

A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering.

FTSE Russell is wholly owned by LSEG.

For more information, visit FTSE Russell.

For more information contact:
The Equity Group
Lena Cati
Senior Vice President
212-836-9611
[email protected]

Release – Alliance Authentic Expands Its Preservation Platform Across Collecting, From Vinyl to Funko to Handmade by Robots

Posted on June 29, 2026June 29, 2026 by [email protected]

Research News and Market Data in AENT

Forbes called Alliance Authentic “a one-of-a-kind platform” for “a new generation of record buyers”

Newly preserved vinyl from Olivia Rodrigo, Harry Styles, Zara Larsson, Charli xcx, Karol G, Hayley Williams, and Angine de Poitrine

Launching newly preserved figures from Funko and Handmade by Robots

PLANTATION, Fla., June 29, 2026 (GLOBE NEWSWIRE) — Alliance Authentic, part of Alliance Entertainment (Nasdaq: AENT), the largest distributor of physical media in the U.S., today expanded its preservation platform beyond vinyl for the first time, launching preserved Funko and Handmade by Robots collectibles. Alliance Authentic is the only platform that preserves the records and collectibles fans care about most and carries each one’s verified identity to every owner who comes next. The company is creating a new category: permanently preserved collectibles. The expansion arrives on a rebuilt Alliance Authentic platform, redesigned around how collectors discover, preserve, and pass on what they own.

Every preserved Alliance Authentic release meets five standards: curated, numbered, limited, certified uncirculated, and NFC-secured. Each collectible is encapsulated in its original, uncirculated condition, individually numbered, and given an NFC-secured identity that travels to whoever owns it next. For vinyl, each preserved run is fixed and final, never added to. When a preserved collectible changes hands, its verified identity, condition, and full history travel with it. Every owner inherits the proof, not just the object. See how preservation works: https://www.allianceauthentic.com/how-preservation-works

“Every collector has a record that means everything to them,” said Jeffrey Smith, SVP of Sales and Marketing at Alliance Authentic. “And it’s not a generational thing, across ages, across collectors, that feeling is the same. We built a preservation system for exactly that, to keep a record in the moment it’s verified, certified, uncirculated, and treat it as the work of art it already is. There’s nothing cooler than an encapsulated Japanese import of Star Wars: A New Hope with the obi strip. And a Handmade by Robots figure or a Funko is just as cool to a different kind of collector. Opening this preservation system up to all of it, that’s what I’m excited about. A fan is a fan of what they love, and we’re here to protect it.”

Visit the new Alliance Authentic and browse the preserved vinyl catalog, home of The Ultimate Vinyl Collectible™: https://allianceauthentic.com

Explore the preserved Handmade by Robots figures, The Ultimate Fan Collectible: https://allianceauthentic.com/shop/search?_pg=hmbr

Explore the preserved Funko collectibles, The Ultimate Fan Collectible: https://allianceauthentic.com/shop/search?_pg=funko

About Alliance Authentic

Alliance Authentic is the only platform that preserves the records and collectibles fans care about most and carries each one’s verified identity to every owner who comes next. Part of Alliance Entertainment (Nasdaq: AENT), the largest distributor of physical media in the U.S. Learn more at allianceauthentic.com.

About Alliance Entertainment

Alliance Entertainment (NASDAQ: AENT) is a premier distributor and fulfillment partner for the entertainment and pop culture collectibles industry. With more than 340,000 unique in-stock SKUs – including over 57,300 exclusive titles across compact discs, vinyl LPs, DVDs, Blu-rays, and video games – Alliance offers the largest selection of physical media in the market. Our vast catalog also includes licensed merchandise, toys, retro gaming products, and collectibles, serving over 35,000 retail locations and powering e-commerce fulfillment for leading retailers. Alliance also owns and operates proprietary collectibles brands, including Handmade by Robots™, a stylized vinyl figure line featuring licensed characters from leading entertainment franchises, and Alliance Authentic™, a premium platform for authentic, certified, and individually numbered entertainment collectibles. In addition, Alliance operates Endstate Authentic, a dedicated NFC-enabled authentication and digital product identity platform supporting authenticated collectibles, resale, and brand protection. Leveraging decades of operational expertise, exclusive sourcing relationships, and a capital-light, scalable infrastructure, Alliance connects fans and collectors to the products, franchises, and experiences they value across formats and generations.

Forward Looking Statements

Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether identified in this Press Release, and on the current expectations of Alliance’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Alliance. These forward-looking statements are subject to a number of risks and uncertainties, including risks relating to the anticipated growth rates and market opportunities; changes in applicable laws or regulations; the ability of Alliance to execute its business model, including market acceptance of its systems and related services; Alliance’s reliance on a concentration of suppliers for its products and services; increases in Alliance’s costs, disruption of supply, or shortage of products and materials; Alliance’s dependence on a concentration of customers, and failure to add new customers or expand sales to Alliance’s existing customers; increased Alliance inventory and risk of obsolescence; Alliance’s significant amount of indebtedness; our ability to refinance our existing indebtedness; our ability to continue as a going concern absent access to sources of liquidity; risks that a breach of the revolving credit facility could result in the lender declaring a default and that the full outstanding amount under the revolving credit facility could be immediately due in full, which would have severe adverse consequences for the Company; known or future litigation and regulatory enforcement risks, including the diversion of time and attention and the additional costs and demands on Alliance’s resources; Alliance’s business being adversely affected by increased inflation, uncertainty regarding tariffs, higher interest rates and other adverse economic, business, and/or competitive factors; geopolitical risk and changes in applicable laws or regulations; as well as our financial condition and results of operations; substantial regulations, which are evolving, and unfavorable changes or failure by Alliance to comply with these regulations; product liability claims, which could harm Alliance’s financial condition and liquidity if Alliance is not able to successfully defend or insure against such claims; availability of additional capital to support business growth; and the inability of Alliance to develop and maintain effective internal controls.

For press inquiries, please contact:

Max Lefkowitz – [email protected]
Anna DeNelsky – [email protected]
Matt Hanks – [email protected]

For investor inquiries, please contact:

Dave Gentry
RedChip Companies, Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
[email protected]

Release – FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes

Posted on June 29, 2026June 29, 2026 by [email protected]

Research News and Market Data on RAIL

06/29/2026

CHICAGO, June 29, 2026 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL) announced today that it has been added to the Russell 2000® and Russell 3000® indexes, effective June 29, 2026.

“We are pleased to be recognized through the inclusion in the Russell indexes, which we view as a reflection of FreightCar America’s growth trajectory and the progress we have made strengthening our business,” said Nick Randall, President and Chief Executive Officer. “Membership in these widely followed benchmarks broadens our visibility within the institutional investment community and reinforces our commitment to creating long-term value for our shareholders.”

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $12.2 trillion in investor assets are benchmarked to or invested in products based on the Russell US Indexes, according to FTSE Russell, a leading global index provider.

The June reconstitution of the Russell US indexes captures up to the 4,000 largest US stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000^® Index, which remains in place for half a year beginning 2026, means automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

For more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.

About FreightCar America

FreightCar America, headquartered in Chicago, Illinois, is a leading designer, producer and supplier of railroad freight cars, railcar parts and components. We also specialize in railcar repairs, complete railcar rebody services and railcar conversions that repurpose idled rail assets back into revenue service. Since 1901, our customers have trusted us to build quality railcars that are critical to economic growth and instrumental to the North American supply chain. To learn more about FreightCar America, visit www.freightcaramerica.com.

Investor Contact: [email protected]

Release – NN, Inc. Announces Significant New Awards for its NVIDIA Data Center Liquid Cooled Products Business

Posted on June 29, 2026June 29, 2026 by [email protected]

PDF Version

CHARLOTTE, N.C., June 29, 2026 (GLOBE NEWSWIRE) — NN, Inc. (“NN” or the “Company”) (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies with six sigma quality, today provided an update on its rapidly growing Data Center business. NN’s combined Data Center and Electric Grid business is already its 2^nd largest business, with a further goal to grow the business into the Company’s largest business by sales. The Data Center & Electric Grid end markets are top targeted growth markets for the Company along with Medical products and Defense and Electronics products.

NN has secured a significant amount of additional 2026 immediate-supply awards for liquid cooling products that go into NVIDIA AI data center racks. The new awards in this announcement are additive to prior communicated awards and greatly increase the size of NN’s liquid cooling product portfolio for AI data center racks.

NN is on its way to having 52 dedicated machines to make liquid cooled products for its data center business. 50 machines will be dedicated production lines and an additional 2 machines will be dedicated to making samples for new business. NN has already pre-sold 100% of the production capacity. NN is continuing to prospect globally and is using its global business development team and global machining footprint to prospect for additional business in this fast-growing area. In 2026, NN has attended Data Center tradeshows in the United States, Europe, and China.

Harold Bevis, President and Chief Executive Officer of NN, Inc. commented, “The liquid-cooled AI data center market is one of our targeted end markets for growth. We announced the successful launch of a new product line in Q1 2026. It is a custom-designed, stainless-steel product line for the liquid-cooled data center market. Since then, we have secured multiple AI data center awards, have invested in an initial complement of 17 next-generation, high-speed, high-precision CNC machines at our Wuxi, China plant, and began production. We have a big set of data center products already but we are just beginning. We make products that go into both the electrical system and cooling system for Data Centers and produce these products in multiple plant locations.

Today, we are pleased to announce that we have tripled the size of the liquid cooling product line that just launched in Q1 2026. Specifically, we have secured another set of multi-year, multi-product awards for stainless-steel cooling products for the NVIDIA supply chain. NN is now underway with procuring an additional 30 new machine centers on top of the 17 new CNC machine centers we previously announced. Additionally, we have successfully repurposed and retooled 5 automotive CNC production centers to become dedicated data center production. We have a strategic goal to rotate out of commodity auto products and this accelerates the achievement of that objective.”

Bevis continued, “We are building a meaningful position in the global supply chain for liquid cooled AI systems. The Wuxi plant had approximately 200 CNC machine centers before successfully entering the data center business. These additional 47 machine centers bring the total in that plant to approximately 250 CNC machine centers when this expansion is complete. We have large aspirations with our global footprint, and the industry needs NN to scale up and supply more. The AI data center liquid cooling industry is scaling very rapidly, and we are participating in the global data center buildout. This is a natural product fit as we are experienced veterans in pressurized fluid management, stainless steel part production, exceptional repetitive quality levels at high volumes, electropolishing, abrasive flow machining, debris-free and leak-free products, and fast innovation.

We have a dedicated company effort to grow Data Center products, and we are happy to have secured our next set of new awards. This expansion and ramp up is underway now during Q2 2026 and will be additive to our 2026 sales. Based on equipment lead times, the 47^th new machine will be installed in November 2026. We are underway prospecting for additional awards and developing new products. As mentioned, the 47 new machines in this announcement will go into NN’s Wuxi, China plant and it will be supplying parts into NVIDIA’s Asia supply chain in China, Taiwan, and Vietnam. NN’s Wuxi China plant is a global low-cost plant that is well known in the metal part making industry. It is in an ideal location for supplying the metal parts that go into the global supply chain for AI data center racks. We believe these data center racks which are being produced in Asia are coming back to the US and being installed in data centers being built in the United States AI market.”

Bevis concluded, “As next generation supply chain decisions are being made in the data center industry, NN intends to use its global footprint of machining plants to participate further. This is a multi-billion market that is scaling up right now, and these computing racks are the hardware behind the expanding use of AI and cloud computing. These new awards fit within NN’s previously issued new wins guidance for achieving $80 to $90 million of accretive new business during 2026. We will combine this new information along with other information and adjust 2026 and 2027 sales and EBITDA guidance, if needed, during NN’s next business and guidance update when we release Q2 earnings in early August. We look forward to discussing this big advancement during that time.”

About NN’s Fluid Management Products

NN is a leader in precision fluid management products for over 40 years. The Company makes precision metal fluid management components including valve body, socket body, valve seat, sealing seat, needle, plunger, plug base, socket base, guides, and threaded connector parts. Given its long-term expertise, NN can make these products in a variety of manners across high-mix, medium-speed single spindle machines as well as high-volume, high-speed production with multi-spindle machines and rotary transfer systems. It makes these products in-house in its plants in China, Europe, South America, and North America. NN makes these products today and has for decades under multi-year contracts for many of the top OEMs in the world. The goal is leak-free, debris-free products that never fail during the life of the equipment.

NN’s existing liquid management products precisely fit the requirements of data center applications, and the demanding performance and quality requirements of AI data center and cloud customers are a direct use of the Company’s existing capabilities. Furthermore, next generation computing designs require even higher power use and even higher heat generation, which will lead to next-generation liquid-cooled computing systems and components. The Company can already make products that are advanced beyond today’s requirements. NN has delivered six sigma quality, micron-level tolerance parts for combustion engines for decades. The Company’s decades of global experience and footprint are directly applicable to this new area.

About NN

NN, Inc., a global diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has facilities in North America, Europe, South America, and China. For more information about the Company and its products, please visit www.nninc.com.

Forward-Looking Statements

This press release contains express and implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding future growth of NN’s liquid-cooled AI data center business, the procurement and timing of additional machines to support the liquid-cooled AI data center business, NN’s aspirations , the size and future outlook of the data center market, NN’s competitive position in the data center market, , expected new business wins for 2026, the Company’s 2026 performance and other statements that are not historical facts.

Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “guidance,” “intend,” “may,” “will,” “possible,” “potential,” “predict,” “project”, “achieve,” “growth,” “enable,” “improve,” or the negative of these terms, and similar words, phrases or expressions that convey uncertainty of future events or outcomes. Forward-looking statements involve a number of risks and uncertainties that are outside of management’s control and that may cause actual results to be materially different from such statements. Such factors include, among others, general economic conditions and economic conditions in the industrial sector; competitive influences; risks that current customers will commence or increase captive production; risks of capacity underutilization; quality issues; inflationary pressures and material changes in the cost or availability of raw materials, supply chain shortages and disruptions, the availability of labor and labor distributions along the supply chain; our dependence on certain major customers, some of whom are not parties to long-term agreements (and/or are terminable on short notice); the impact of acquisitions and divestitures, as well as expansion of end markets and product officers; our ability to hire or retain key personnel; the restrictions contained in our debt agreements; the level of our indebtedness and our ability to obtain financing at favorable rates, if at all, or to refinance existing debt as it matures; our ability to secure, maintain or enforce patents or other appropriate protections for our intellectual property; the impact on climate change on our operations; economic, social and geopolitical instability, military conflict, current fluctuation, and other risks of doing business outside of the United States; and uncertainty of government policies and actions in respect to global trade and tariffs, including the potential impacts of tariffs on the United States economy, the economy of other countries in which we conduct operations and our industry, cyber liability or potential liability for breaches of our or our service providers’ information technology systems or business operations disruptions. The foregoing factors should not be construed as exhaustive and should be read in conjunction with the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s filings made with the U.S. Securities and Exchange Commission. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. New risks and uncertainties may emerge from time to time, and it is not possible for the Company to predict their occurrence or how they will affect the Company. The Company qualifies all forward-looking statements by these cautionary statements.

Investor Relations:
Joseph Caminiti
[email protected]
312-445-2870